Cargando…

Constitutive inhibitory G protein activity upon adenylyl cyclase-dependent cardiac contractility is limited to adenylyl cyclase type 6

PURPOSE: We previously reported that inhibitory G protein (G(i)) exerts intrinsic receptor-independent inhibitory activity upon adenylyl cyclase (AC) that regulates contractile force in rat ventricle. The two major subtypes of AC in the heart are AC5 and AC6. The aim of this study was to determine i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bull Melsom, Caroline, Cosson, Marie-Victoire, Ørstavik, Øivind, Lai, Ngai Chin, Hammond, H. Kirk, Osnes, Jan-Bjørn, Skomedal, Tor, Nikolaev, Viacheslav, Levy, Finn Olav, Krobert, Kurt Allen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556981/
https://www.ncbi.nlm.nih.gov/pubmed/31173603
http://dx.doi.org/10.1371/journal.pone.0218110
_version_ 1783425400452415488
author Bull Melsom, Caroline
Cosson, Marie-Victoire
Ørstavik, Øivind
Lai, Ngai Chin
Hammond, H. Kirk
Osnes, Jan-Bjørn
Skomedal, Tor
Nikolaev, Viacheslav
Levy, Finn Olav
Krobert, Kurt Allen
author_facet Bull Melsom, Caroline
Cosson, Marie-Victoire
Ørstavik, Øivind
Lai, Ngai Chin
Hammond, H. Kirk
Osnes, Jan-Bjørn
Skomedal, Tor
Nikolaev, Viacheslav
Levy, Finn Olav
Krobert, Kurt Allen
author_sort Bull Melsom, Caroline
collection PubMed
description PURPOSE: We previously reported that inhibitory G protein (G(i)) exerts intrinsic receptor-independent inhibitory activity upon adenylyl cyclase (AC) that regulates contractile force in rat ventricle. The two major subtypes of AC in the heart are AC5 and AC6. The aim of this study was to determine if this intrinsic G(i) inhibition regulating contractile force is AC subtype selective. METHODS: Wild-type (WT), AC5 knockout (AC5KO) and AC6 knockout (AC6KO) mice were injected with pertussis toxin (PTX) to inactivate G(i) or saline (control).Three days after injection, we evaluated the effect of simultaneous inhibition of phosphodiesterases (PDE) 3 and 4 with cilostamide and rolipram respectively upon in vivo and ex vivo left ventricular (LV) contractile function. Also, changes in the level of cAMP were measured in left ventricular homogenates and at the membrane surface in cardiomyocytes obtained from the same mouse strains expressing the cAMP sensor pmEPAC1 using fluorescence resonance energy transfer (FRET). RESULTS: Simultaneous PDE3 and PDE4 inhibition increased in vivo and ex vivo rate of LV contractility only in PTX-treated WT and AC5KO mice but not in saline-treated controls. Likewise, Simultaneous PDE3 and PDE4 inhibition elevated total cAMP levels in PTX-treated WT and AC5KO mice compared to saline-treated controls. In contrast, simultaneous PDE3 and PDE4 inhibition did not increase in vivo or ex vivo rate of LV contractility or cAMP levels in PTX-treated AC6KO mice compared to saline-treated controls. Using FRET analysis, an increase of cAMP level was detected at the membrane of cardiomyocytes after simultaneous PDE3 and PDE4 inhibition in WT and AC5KO but not AC6KO. These FRET data are consistent with the functional data indicating that AC6 activity and PTX inhibition of G(i) is necessary for simultaneous inhibition of PDE3 and PDE4 to elicit an increase in contractility. CONCLUSIONS: Together, these data suggest that AC6 is tightly regulated by intrinsic receptor-independent G(i) activity, thus providing a mechanism for maintaining low basal cAMP levels in the functional compartment that regulates contractility.
format Online
Article
Text
id pubmed-6556981
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-65569812019-06-17 Constitutive inhibitory G protein activity upon adenylyl cyclase-dependent cardiac contractility is limited to adenylyl cyclase type 6 Bull Melsom, Caroline Cosson, Marie-Victoire Ørstavik, Øivind Lai, Ngai Chin Hammond, H. Kirk Osnes, Jan-Bjørn Skomedal, Tor Nikolaev, Viacheslav Levy, Finn Olav Krobert, Kurt Allen PLoS One Research Article PURPOSE: We previously reported that inhibitory G protein (G(i)) exerts intrinsic receptor-independent inhibitory activity upon adenylyl cyclase (AC) that regulates contractile force in rat ventricle. The two major subtypes of AC in the heart are AC5 and AC6. The aim of this study was to determine if this intrinsic G(i) inhibition regulating contractile force is AC subtype selective. METHODS: Wild-type (WT), AC5 knockout (AC5KO) and AC6 knockout (AC6KO) mice were injected with pertussis toxin (PTX) to inactivate G(i) or saline (control).Three days after injection, we evaluated the effect of simultaneous inhibition of phosphodiesterases (PDE) 3 and 4 with cilostamide and rolipram respectively upon in vivo and ex vivo left ventricular (LV) contractile function. Also, changes in the level of cAMP were measured in left ventricular homogenates and at the membrane surface in cardiomyocytes obtained from the same mouse strains expressing the cAMP sensor pmEPAC1 using fluorescence resonance energy transfer (FRET). RESULTS: Simultaneous PDE3 and PDE4 inhibition increased in vivo and ex vivo rate of LV contractility only in PTX-treated WT and AC5KO mice but not in saline-treated controls. Likewise, Simultaneous PDE3 and PDE4 inhibition elevated total cAMP levels in PTX-treated WT and AC5KO mice compared to saline-treated controls. In contrast, simultaneous PDE3 and PDE4 inhibition did not increase in vivo or ex vivo rate of LV contractility or cAMP levels in PTX-treated AC6KO mice compared to saline-treated controls. Using FRET analysis, an increase of cAMP level was detected at the membrane of cardiomyocytes after simultaneous PDE3 and PDE4 inhibition in WT and AC5KO but not AC6KO. These FRET data are consistent with the functional data indicating that AC6 activity and PTX inhibition of G(i) is necessary for simultaneous inhibition of PDE3 and PDE4 to elicit an increase in contractility. CONCLUSIONS: Together, these data suggest that AC6 is tightly regulated by intrinsic receptor-independent G(i) activity, thus providing a mechanism for maintaining low basal cAMP levels in the functional compartment that regulates contractility. Public Library of Science 2019-06-07 /pmc/articles/PMC6556981/ /pubmed/31173603 http://dx.doi.org/10.1371/journal.pone.0218110 Text en © 2019 Bull Melsom et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Bull Melsom, Caroline
Cosson, Marie-Victoire
Ørstavik, Øivind
Lai, Ngai Chin
Hammond, H. Kirk
Osnes, Jan-Bjørn
Skomedal, Tor
Nikolaev, Viacheslav
Levy, Finn Olav
Krobert, Kurt Allen
Constitutive inhibitory G protein activity upon adenylyl cyclase-dependent cardiac contractility is limited to adenylyl cyclase type 6
title Constitutive inhibitory G protein activity upon adenylyl cyclase-dependent cardiac contractility is limited to adenylyl cyclase type 6
title_full Constitutive inhibitory G protein activity upon adenylyl cyclase-dependent cardiac contractility is limited to adenylyl cyclase type 6
title_fullStr Constitutive inhibitory G protein activity upon adenylyl cyclase-dependent cardiac contractility is limited to adenylyl cyclase type 6
title_full_unstemmed Constitutive inhibitory G protein activity upon adenylyl cyclase-dependent cardiac contractility is limited to adenylyl cyclase type 6
title_short Constitutive inhibitory G protein activity upon adenylyl cyclase-dependent cardiac contractility is limited to adenylyl cyclase type 6
title_sort constitutive inhibitory g protein activity upon adenylyl cyclase-dependent cardiac contractility is limited to adenylyl cyclase type 6
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556981/
https://www.ncbi.nlm.nih.gov/pubmed/31173603
http://dx.doi.org/10.1371/journal.pone.0218110
work_keys_str_mv AT bullmelsomcaroline constitutiveinhibitorygproteinactivityuponadenylylcyclasedependentcardiaccontractilityislimitedtoadenylylcyclasetype6
AT cossonmarievictoire constitutiveinhibitorygproteinactivityuponadenylylcyclasedependentcardiaccontractilityislimitedtoadenylylcyclasetype6
AT ørstavikøivind constitutiveinhibitorygproteinactivityuponadenylylcyclasedependentcardiaccontractilityislimitedtoadenylylcyclasetype6
AT laingaichin constitutiveinhibitorygproteinactivityuponadenylylcyclasedependentcardiaccontractilityislimitedtoadenylylcyclasetype6
AT hammondhkirk constitutiveinhibitorygproteinactivityuponadenylylcyclasedependentcardiaccontractilityislimitedtoadenylylcyclasetype6
AT osnesjanbjørn constitutiveinhibitorygproteinactivityuponadenylylcyclasedependentcardiaccontractilityislimitedtoadenylylcyclasetype6
AT skomedaltor constitutiveinhibitorygproteinactivityuponadenylylcyclasedependentcardiaccontractilityislimitedtoadenylylcyclasetype6
AT nikolaevviacheslav constitutiveinhibitorygproteinactivityuponadenylylcyclasedependentcardiaccontractilityislimitedtoadenylylcyclasetype6
AT levyfinnolav constitutiveinhibitorygproteinactivityuponadenylylcyclasedependentcardiaccontractilityislimitedtoadenylylcyclasetype6
AT krobertkurtallen constitutiveinhibitorygproteinactivityuponadenylylcyclasedependentcardiaccontractilityislimitedtoadenylylcyclasetype6